Literature DB >> 3967458

Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.

J Kuhlmann.   

Abstract

To determine whether nifedipine or diltiazem affect digoxin kinetics, glycoside plasma concentrations and renal excretion were measured before and during dosing in 23 patients with cardiac insufficiency achieving steady-state conditions. Mean (+/- SD) digoxin plasma concentration was 0.64 +/- 0.22 before and 0.61 +/- 0.21 ng/ml during nifedipine dosing in 11 subjects over a period of 10 to 14 days. Renal digoxin clearance was not influenced by nifedipine, whereas total body clearance and extrarenal clearance of digoxin increased slightly. In contrast, diltiazem resulted in a 24% to 70% (means = 46%) increase in plasma digoxin concentrations in eight of 12 subjects. Renal digoxin clearance was not influenced by diltiazem, whereas total body clearance and extrarenal clearance of digoxin were reduced 28% and 44% in five of the eight subjects in whom renal digoxin excretion was measured. From these data it was concluded that nifedipine has no significant effects on digoxin kinetics, but that digoxin plasma concentrations should be controlled in subjects receiving digoxin with diltiazem until new steady-state digoxin concentrations are established, and that the digoxin dose be reduced if there is evidence of toxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967458     DOI: 10.1038/clpt.1985.27

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 4.  Digitalis toxicity--turning over a new leaf?

Authors:  S J Bhatia
Journal:  West J Med       Date:  1986-07

5.  Digoxin-felodipine interaction in patients with congestive heart failure.

Authors:  P H Dunselman; A H Scaf; C E Kuntze; K I Lie; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Digoxin-diltiazem interaction: a pharmacokinetic evaluation.

Authors:  W N Jones; K B Kern; J P Rindone; M Mayersohn; M Bliss; S Goldman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin.

Authors:  W Kirch; J Stenzel; P Dylewicz; H J Hutt; S R Santos; E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

Review 8.  Diltiazem. A review of its pharmacology and therapeutic use in older patients.

Authors:  A Markham; R N Brogden
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

Review 9.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

10.  Effect of two different doses of nitrendipine on steady-state plasma digoxin level and systolic time intervals.

Authors:  W Kirch; C Logemann; H Heidemann; S R Santos; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.